Wallace Medipharma LLP
About Wallace Medipharma LLP
Data last updated:
Wallace Medipharma LLP is a limited liability partnership (LLP) based in Panaji, Goa, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 26 February 2020 and has been in existence for over 6 years.
The LLP is registered with the Registrar of Companies (ROC), Goa, under LLPIN AAS-0492.
The LLP has a total obligation of contribution of ₹9.2 Lakh. It is led by designated partners Maria Emilia Dias Menezes and Cesar Mauricio Jose De Menezes.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at House No. 302 Edc Complex Patto, Panaji, Goa, India – 403001.
As per the financials filed for FY 2024, the LLP reported a revenue of ₹19.18 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹10,325 (net margin -0.5%) and EBITDA of -₹9,293 (EBITDA margin -0.5%). Revenue has grown at a compounded annual rate (CAGR) of 228% over three years.
Company details
Contact details
Wallace Medipharma LLP's registered office is in Panaji, Goa.
- Registered AddressHouse No. 302 Edc Complex Patto, Panaji, Goa, India – 403001
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Wallace Medipharma LLP
FY 2025 filings availableWallace Medipharma LLP reported revenue of ₹19.18 Lakh (up 7198% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 228% over three years. EBITDA fell 100% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | |||||
| Other Income | |||||
| Total Income | |||||
| Purchases and Direct Costs | |||||
| Personnel Expenses | |||||
| Administrative Expenses | |||||
| Interest | |||||
| Depreciation | |||||
| Total Expenses | |||||
| Profit Before Tax | |||||
| Tax | |||||
| Profit After Tax | -₹10,325 | ||||
| Profit Transferred to Partners | |||||
| Assets and Liabilities | |||||
| Partners' Contribution | |||||
| Reserves and Surplus | |||||
| Secured Loans | |||||
| Unsecured Loans | |||||
| Trade Payables | |||||
| Other Liabilities and Provisions | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Loans and Advances | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | -0.5% | ||||
| Return on Partners' Funds | |||||
| Return on Assets | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Debt to Partners' Funds | |||||
| Interest Coverage | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Turnover Growth | |||||
| Profit Growth | |||||
To see the full financial statements and ratios of Wallace Medipharma LLP, buy the company report.
Designated partners of Wallace Medipharma LLP
Wallace Medipharma has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Maria Emilia Dias Menezes | Designated Partner | 26 Feb 2020 | 6 Years 8 Months | Current |
| Cesar Mauricio Jose De Menezes | Designated Partner | 26 Feb 2020 | 6 Years 8 Months | Current |
Peer comparison
Wallace Medipharma LLP is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Novastella Healthcare Private Limited | ₹19.34 Lakh (FY 2025) | -33.0% | Kolkata, West Bengal, India | |||
| Impex Pharmacare Private Limited | ₹19.32 Lakh (FY 2023) | -32.0% | Mumbai, Maharashtra, India | |||
| Bionol Lifesciences Private Limited | ₹19.31 Lakh (FY 2024) | -2.0% | Lucknow, Uttar Pradesh, India | |||
| PV Healthcare Private Limited | ₹19.27 Lakh (FY 2025) | 38.0% | Mumbai, Maharashtra, India | |||
| Zeevet Animal Health Private Limited | ₹19.21 Lakh (FY 2025) | 162.0% | Karchhana, Uttar Pradesh, India | |||
| Wallace Medipharma LLPthis company | ₹19.18 Lakh (FY 2024) | -₹10,325 | -0.5% | 7198.0% | Panaji, Goa, India | |
| Manish Medicates Private Limited | ₹19.16 Lakh (FY 2020) | -85.0% | Indore, Madhya Pradesh, India | |||
| Laxifs Lifesciences Private Limited | ₹19.16 Lakh (FY 2025) | -56.0% | Palghar, Maharashtra, India | |||
| Axis Labs Private Limited | ₹19.16 Lakh (FY 2025) | -17.0% | Delhi, India | |||
| P and G Ahuja Biotech Limited | ₹19.15 Lakh (FY 2024) | -12.0% | Sanathal, Gujarat, India | |||
| Vpmvet99 Pharma Private Limited | ₹19.1 Lakh (FY 2021) | -21.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Wallace Medipharma LLP, buy the company report.
Legal cases
No court or tribunal cases involving Wallace Medipharma LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Wallace Medipharma LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Wallace Medipharma LLP; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Wallace Medipharma LLP has 2 designated partner changes on record since 2020: 2 appointments. The latest: Cesar Mauricio Jose De Menezes was appointed as Designated Partner on 26 Feb 2020.
Frequently asked questions
Wallace Medipharma is an active limited liability partnership based in Panaji, Goa, India. The LLP works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 26 February 2020 (6+ years old) and is registered under LLPIN AAS-0492.
Wallace Medipharma has 2 current designated partners:
- Maria Emilia Dias Menezes - Designated Partner
- Cesar Mauricio Jose De Menezes - Designated Partner
The latest financial statements of Wallace Medipharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2020 are in the company report.
The LLPIN (Limited Liability Partnership Identification Number) of Wallace Medipharma is AAS-0492. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Wallace Medipharma was incorporated on 26 February 2020, making it 6+ years old. It is registered with the Registrar of Companies, Goa.
The peers of Wallace Medipharma by revenue are Novastella Healthcare Private Limited, Impex Pharmacare Private Limited, Bionol Lifesciences Private Limited, PV Healthcare Private Limited, Zeevet Animal Health Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Cesar Mauricio Jose De Menezes was appointed as Designated Partner on 26 Feb 2020. Maria Emilia Dias Menezes was appointed as Designated Partner on 26 Feb 2020.
The registered office of Wallace Medipharma is at House No. 302 Edc Complex Patto, Panaji, Goa, India – 403001.
Wallace Medipharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Wallace Medipharma can be reached at its registered office: House No. 302 Edc Complex Patto, Panaji, Goa, India – 403001.
Wallace Medipharma is registered under the jurisdiction of the Registrar of Companies (ROC), Goa.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
